Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) ...

Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Rural populations face unique challenges in cancer prevention and care. Geographic isolation, economic constraints, and a ...

The company has also partnered with the Tata Institute for Genetics and Society (TIGS) to develop an Indigenous HPV PCR kit, ...

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

Women in Papua New Guinea are being strongly encouraged to undergo early screening for cervical cancer to prevent the ...

Japan approves Tivdak, the first ADC for cervical cancer ... TIVDAK compared to chemotherapy in patients with advanced or recurrent cervical cancer who were previously treated with chemotherapy.

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian, endometrial, and cervical cancers.

In Côte d'Ivoire, nearly 90% of cervical cancer screenings are conducted through self-testing, empowering women to take charge of their health. This approach allows for detection in a private, ...

Please provide your email address to receive an email when new articles are posted on . Results showed an objective response rate of 100% and a 12-month PFS of 74.9%. AK104 with concurrent ...